News

Article

Ophthalmologist tapped by Clinique to educate consumers on eye safety

Author(s):

The beauty brand announces Ashley Brissette, MD, MSc, FRCSC, will be the brand's first guiding ophthalmologist.

(image Credit: Clinique)

(Image Credit: Clinique)

Clinique, a dermatologist-developed beauty brand, has named Ashley Brissette, MD, MSc, FRCSC, as the brand's first guiding ophthalmologist.

According to a news release, in the newly created role, Brissette, aNew York City-based ophthalmologist, will join Clinique in its mission to educate consumers on the importance of eye safety, offer her ophthalmological expertise and guidance in the development of new products, and contribute to the brand’s educational content for consumers and consultants.

Clinique noted in its news release it has been focused on delivering effective and safe formulas for consumers since 1968.

“This commitment to safety starts from science with products evaluated at different stages of development to ensure they meet the brand's highest standards of safety and efficacy,” the company said in its news release. “Clinique's decades of research informs both today and tomorrow's formulations.”

Moreover, the company noted its safety mission is rooted in Clinique's Eye Promise, ensuring that all eye makeup products are ophthalmologist-tested, and safe for sensitive eyes and contact lens wearers. Behind every high-performance mascara, liner and lid color, are hundreds of rigorous safety evaluations, delivering on Clinique's commitment to consumers.

‘We are thrilled to welcome Dr. Brissette to the Clinique family, inspired by her impact in the ophthalmology field in both her contributions to medical literature and in her work with daily patients,” Janet Pardo, Senior Vice President, Global Product Development, Clinique, said in the news release. “We look forward to this partnership including the critical expertise and insights she brings in helping Clinique continue to carry out our commitment to safety at every step’"

Brissette said in the release that she is passionate about education and is pleased to partner with Clinique and their mission of eye safety.

“This partnership highlights the brands integrity and dedication to creating safe yet effective eye products, and I look forward to exciting new advances ahead," Brissette said in the release.

According to the company, Brissette specializes in ocular surface diseases and cataract and laser corrective surgery. She serves as a spokesperson for the American Academy of Ophthalmology and is an ophthalmologist for the New York Rangers NHL hockey team.

The first campaign featuring Brissette will be for Clinique's New High Impact High-Fi Full Volume Mascara

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.